Stuart A. Kinner is with the Melbourne School of Population and Global Health, University of Melbourne, VIC, Australia, and the School of Medicine, University of Queensland, Brisbane, Australia. Emily A. Wang is with the Section of General Internal Medicine, Department of Medicine, Yale University, New Haven, CT.
Am J Public Health. 2014 Aug;104(8):1352-5. doi: 10.2105/AJPH.2014.301883. Epub 2014 Jun 12.
The global prison population exceeds 10 million and continues to grow; more than 30 million people are released from custody annually. These individuals are disproportionately poor, disenfranchised, and chronically ill. There are compelling, evidence-based arguments for improving health outcomes for ex-prisoners on human rights, public health, criminal justice, and economic grounds. These arguments stand in stark contrast to current policy and practice in most settings. There is also a dearth of evidence to guide clinicians and policymakers on how best to care for this large and growing population during and after their transition from custody to community. Well-designed longitudinal studies, clinical trials, and burden of disease studies are pivotal to closing this evidence gap.
全球监狱人口超过 1000 万，并持续增长；每年有超过 3000 万人获释。这些人绝大多数都贫困、被剥夺权利且患有慢性病。从人权、公共卫生、刑事司法和经济角度来看，改善前囚犯的健康结果有强有力的、基于证据的论据。这些论据与大多数环境下的现行政策和做法形成鲜明对比。此外，在囚犯从监禁过渡到社区期间和之后，如何最好地照顾这一庞大且不断增长的人群，这方面的证据也十分匮乏，难以指导临床医生和政策制定者。精心设计的纵向研究、临床试验和疾病负担研究对于缩小这一证据差距至关重要。
